Ivee Injectaa Limited announced unaudited standalone earnings results for third quarter and nine months ended December 31, 2015. For the quarter, the company reported loss from operations before finance cost and exceptional items was INR 0.098 million compared to INR 0.041 million for the same period a year ago. Loss from ordinary activities before tax was INR 0.098 million compared to INR 0.041 million for the same period a year ago. Net loss was INR 0.098 million or INR 0.52 per basic and diluted share before and after extraordinary items compared to net loss of INR 0.041 million or INR 0.01 per basic and diluted share before and after extraordinary items for the same period a year ago.

For the nine months, the company reported loss from operations before finance cost and exceptional items was INR 0.478 million compared to INR 0.378 million for the same period a year ago. Loss from ordinary activities before tax was INR 0.478 million compared to INR 0.378 million for the same period a year ago. Net loss was INR 0.478 million or INR 2.54 per basic and diluted share before and after extraordinary items compared to net loss of INR 0.378 million or INR 0.10 per basic and diluted share before and after extraordinary items for the same period a year ago.